EA
CCXI

Emerald Advisers’s ChemoCentryx, Inc. CCXI Stock Holding History

Emerald Advisers’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-214,672
Closed -$11M – 306
2021
Q1 		$11M Sell
214,672
-249,289
-54% -$15M 0.4% 98
2020
Q4 		$28.7M Buy
463,961
+78,855
+20% +$4.51M 0.95% 34
2020
Q3 		$21.1M Sell
385,106
-16,733
-4% -$901K 0.87% 44
2020
Q2 		$23.1M Buy
401,839
+27,105
+7% +$1.48M 1.01% 38
2020
Q1 		$15.1M Buy
374,734
+201,514
+116% +$8.56M 0.87% 42
2019
Q4 		$6.85M Buy
+173,220
New +$3.04M 0.29% 109

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Emerald Advisers's CCXI Position: Q2 2021 in Review

Emerald Advisers sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 214,672 shares — an estimated $11M sold.

Emerald Advisers first reported a position in CCXI in Q4 2019 and held it in 6 quarters. The position peaked at $28.7M in Q4 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

  • Emerald Advisers reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
  • Emerald Advisers sold 214,672 ChemoCentryx, Inc. shares in Q2 2021, an estimated $11M.
  • Emerald Advisers first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 6 quarters.
  • Emerald Advisers's ChemoCentryx, Inc. position peaked at $28.7M in Q4 2020.
  • 146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Emerald Advisers's 13F filing for Q2 2021, filed 29 Jul 2021.